SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : wla(warner lambert)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bull-like who wrote (597)3/23/1999 10:44:00 AM
From: Anthony Wong  Read Replies (1) of 942
 
Warner-Lambert Reiterated Short-Term 'Outperform' at Everen

Bloomberg News
March 23, 1999, 10:30 a.m. ET

Princeton, New Jersey, March 23 (Bloomberg Data) -- Warner-Lambert Co.
(WLA US) was reiterated short-term ''outperform'' by analyst Jeffrey J. Kraws
at Everen Securities. The long-term rating was also reiterated ''outperform.''
The intermediate and long-term price targets are $88 and $94. per share,
respectively.

-- Donna McDonald in Princeton, New Jersey, (609)279-3731

(Story illustration: For a chart of the company's stock
prices, see WLA US GP D.

For more company news and information, see WLA US
BR, BQ, CN, COMP, TRA. For more country and industry news, see NI DRG, NI
HOU,
NI NJ, NI US, NI ANA.

For more rating changes, see BBSA2)

-0- ( ) Mar/23/ 99 10:30

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext